Late Sodium Current Blockade in High-Risk ICD Patients
Phase of Trial: Phase III
Latest Information Update: 03 Sep 2018
Price : $35 *
At a glance
- Drugs Ranolazine (Primary)
- Indications Arrhythmias; Cardiomyopathies; Heart failure
- Focus Therapeutic Use
- Acronyms RAID
- 07 Aug 2018 Primary endpoint (Number of Patients With Ventricular Tachycardia or Ventricular Fibrillation or Death) has been met, according to results published in the Journal of the American College of Cardiology.
- 07 Aug 2018 Results (n=1012) published in the Journal of the American College of Cardiology.
- 24 Mar 2017 Status changed from active, no longer recruiting to completed.